LRHC vs NIVF

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Aug 03, 2026

LRHC

51.0
AI Score
VS
LRHC Wins

NIVF

45.6
AI Score

Investment Advisor Scores

LRHC

51score
Recommendation
HOLD

NIVF

46score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric LRHC NIVF Winner
Forward P/E 0 0.06 Tie
PEG Ratio 0 0 Tie
Revenue Growth 8.8% 11.9% NIVF
Earnings Growth 0.0% 0.0% Tie
Tradestie Score 51.0/100 45.6/100 LRHC
Profit Margin -44.6% 209.0% NIVF
Beta 1.00 1.00 Tie
AI Recommendation HOLD HOLD Tie

Relative Price Performance (Last 90 Days)

LRHC 1M: -16.5% · 3M: -54.5% NIVF 1M: +41.4% · 3M: -61.9%

Current Technical Phase

LRHC

Markdown
Sell / avoid

Price below a falling SMA50 (slope -19.5%), weak momentum, RSI 39

RSI (14): 38.7 · Price: $0.86

NIVF

Markdown
Sell / avoid

Price below a falling SMA50 (slope -8.4%), weak momentum, RSI 31

RSI (14): 31.2 · Price: $0.65

Fundamentals Snapshot

Metric LRHC NIVF
Market Cap
Forward P/E 0.0 0.0
Trailing P/E 0.0
Revenue (TTM)
Revenue Growth 0.1% 0.1%
Gross Margin 0.1% 0.2%
Operating Margin -0.2% -3.5%
EPS -1658.61 109.44
Dividend Yield

Frequently Asked Questions

Based on our detailed analysis, LRHC is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.